Table 1.
Studies selected for the meta-analysis, characteristics.
| Author | Year | Country | Time Frame | DP-CAR | DP | Age (DP-CAR/DP) | Gender (M/F) |
AJCC T (DP-CAR/DP) | Neoadjuvant Therapy (DP-CAR/DP) | Survival Outcome/Months (DP-CAR/DP) |
|---|---|---|---|---|---|---|---|---|---|---|
| Beane | 2015 | USA | 2011–2012 | 20 | 172 | 64/66 | 6/14 | NR | NR | NR |
| Ham | 2015 | Korea | 2000–2014 | 7 | 31 | 58/67.5 | 3/4 | T1: 0/1 T2: 0/3 T3: 4/25 T 4: 4/2 |
NR | 15/25 |
| Hishinuma | 2007 | Japan | 1987–2003 | 7 | 18 | 63.8/NR | 4/3 | T1: 0/NR T2: 0/NR T3: 6/NR T4: 1/NR |
NR | 19/25 |
| Malinka | 2020 | Germany | 2005–2018 | 20 | 20 | 60.75/65.05 | 11/9 | T1/1/3 T2:3/2 T3: 12/15 T4: 2/0 |
5/4 | NR |
| Okada | 2012 | Japan | 2005–2010 | 16 | 36 | 63/68 | 11/7 | NR | NR | 25/25 |
| Peters | 2016 | USA | 2004–2016 | 17 | 51 | 64.5/67 | 9/8 | T1: 6/13 T2: 3/25 T3: 1/11 T4: 7/1 |
15/45 | 20/19 |
| Storkholm | 2020 | Denmark | 2013–2017 | 21 | 68 | 62.3/58.3 | 13/8 | T1: 0/5 T2: 3/17 T3: 6/46 T4: 2/0 |
3/0 | 24/23.5 |
| Sugiura | 2017 | Japan | 2002–2014 | 16 | 76 | 70/71 | 10/6 | NR | NR | 17.5/43.1 |
| Takahashi | 2011 | Japan | 1993–2010 | 16 | 27 | 65/70 | 8/16 | T1: 0/5 T2: 0/3 T3: 8/19 T4: 8/0 |
0/0 | 9.7/30.9 |
| Wu | 2010 | China | 2003–2008 | 9 | 34 | 55.6/62.1 | 4/5 | NR | NR | 14/15 |
| Yamamoto | 2017 | Japan | 2001–2012 | 72 | 323 | 64/66 | 40/32 | T1: 3/27 T2: 0/28 T3: 57/267 T4:12/1 |
40/56 | 17.5/28.6 |
P-CAR: distal pancreatectomy with celiac axis resection; DP: distal pancreatectomy; M: male; F: female; AJCC: American Joint Committee on Cancer; NR: not reported.